SCHEMBL20036493

SCHEMBL20036493

CC/C(C)=C\CCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13392977 1.00
SCHEMBL20848266 0.91 DNM1 (0.40)
SCHEMBL107516 0.79
SCHEMBL107517 0.79
SCHEMBL11326532 0.78 SQLE (0.45)
SCHEMBL2001111 0.77 EP300 (0.46)
SCHEMBL73316 0.77 EP300 (0.46)
SCHEMBL10754515 0.76
SCHEMBL8055124 0.76
SCHEMBL25571306 0.75 SQLE (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021053507-A1 2-AMINO-S6-SUBSTITUTED THIOPURINE COMPOUNDS AS INHIBITORS OF THE ENPP1 PROTEIN ATEN PORUS LIFESCIENCES PVT. LTD. (IN) 2021-03-25 WO disclosed
EP-3453393-A1 NOVEL QUINAZOLINONE DERIVATIVES INHIBITING PI3K AND PHARMACEUTICAL COMPOSITION CONTAINING SAME Bioway., Inc (KR) 2019-03-13 EP disclosed
EP-2973823-B1 FUEL CELL SYSTEM WITH INTERCONNECT LG FUEL CELL SYSTEMS INC (US) 2018-04-11 EP disclosed